Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
ASX April 2026 Stocks Estimated To Be Trading Below Fair Value [Yahoo! Finance]
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
Mesoblast R&D Day: Ryonsel Gains Traction, Back Pain Phase III Nears Finish, New Shots on Goal [Yahoo! Finance]
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation